UCI president Hein Verbruggen with Lance Armstrong in 2002
view thumbnail gallery
American also returned suspicious test at 2002 Dauphiné
Lance Armstrong provided a suspicious doping control at the 2001 Tour de Suisse but did not test positive for EPO, according to Martial Saugy, the director of the Lausanne laboratory which carried out the tests.
Floyd Landis and Tyler Hamilton both testified to the US Anti-Doping Agency that Armstrong had told them that he had tested positive in Switzerland in 2001 but that the UCI had covered up the result. The UCI has denied any such collusion.
Speaking to AFP, Saugy said that Armstrong did not test positive for EPO but his sample was one of the three from the race to be flagged as “suspect.” As an “important competitor,” Armstrong was called before the UCI to provide an explanation. Armstrong returned another such suspect sample at the Dauphiné Liberé in 2002, which was analysed by a different laboratory.
“There was no positive test on the Tour of Switzerland in 2001,” Saugy told AFP. “Armstrong had another suspect result during the 2002 Dauphiné Liberé. The politics of the UCI at that time, if there was such a result involving an important competitor, was to meet them and ask for an explanation. That was their approach to prevention.”
Saugy said that it was only in 2002 that he realised that Armstrong had been among the riders who had returned a suspect sample at the Tour de Suisse.
“The UCI said to me at the end of June 2002: ‘we warned the rider for whom you had a suspect result in 2001, he gave another suspect return at another lab and he would like to know by which method it was tested,’” Saugy said. “The rider was Armstrong. It was then that I learned about it.”
Saugy also noted that while Armstrong’s sample from the 2001 Tour de Suisse was suspicious, from a legal standpoint, it would be difficult for USADA to consider it as a positive test.
“There’s no way today that this could be defended as a positive result, it’s impossible,” he said. “Since 2003, procedures oblige taking into account the risks of a false-positive which could verify that urine
To read the whole story, visit here: http://feedproxy.google.com/~r/cyclingnews/news/~3/67uhOJWf3gs/story01.htm
MOST POPULARAlberto Contador Amgen Tour of California Andy Schleck BMX Bradley Wiggins Cadel Evans Cervélo Chris Froome Cyclo-cross Doping Euskaltel-Euskadi Fabian Cancellara Garmin Giro d'Italia HTC Lance Armstrong Levi Leipheimer Liquigas Lotto Mark Cavendish Mountain Biking Movistar Olympics Omega Pharma Paris-Roubaix Pat McQuaid Peter Sagan QuickStep Rabobank RadioShack Road Cycling Ryder Hesjedal Saxo Bank Shimano Taylor Phinney Team Sky Thor Hushovd Tom Boonen Tour de France Track Cycling Trek Tyler Farrar UCI Vincenzo Nibali WorldTour
- Kenny Butler’s Leadville bike equipped for his prosthetic
- Jim Penseyres Ride to Recovery Rider at the Leadville Trail 100
- Rodgers on Stage 20
- Sean Yates on Sky’s success at the 2012 TdF
- Wiggins jumps on team car after winning the 2012 Tour De France
- Cadel Evans on his 2012 Tour de France
- Dave Brailsford on Cav after Stage 18
- Wilfried Peeters on Quick Steps 2012 Tour De France
- Rusch after the Rush: Silver Rush 50 was really heads up
- Roche on Stage 17 and his own GC standing